Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.

Noviello M, Manfredi F, Ruggiero E, Perini T, Oliveira G, Cortesi F, De Simone P, Toffalori C, Gambacorta V, Greco R, Peccatori J, Casucci M, Casorati G, Dellabona P, Onozawa M, Teshima T, Griffioen M, Halkes CJM, Falkenburg JHF, Stölzel F, Altmann H, Bornhäuser M, Waterhouse M, Zeiser R, Finke J, Cieri N, Bondanza A, Vago L, Ciceri F, Bonini C.

Nat Commun. 2019 Mar 25;10(1):1065. doi: 10.1038/s41467-019-08871-1.

2.

Casting a wider net: Immunosurveillance by nonclassical MHC molecules.

D'Souza MP, Adams E, Altman JD, Birnbaum ME, Boggiano C, Casorati G, Chien YH, Conley A, Eckle SBG, Früh K, Gondré-Lewis T, Hassan N, Huang H, Jayashankar L, Kasmar AG, Kunwar N, Lavelle J, Lewinsohn DM, Moody B, Picker L, Ramachandra L, Shastri N, Parham P, McMichael AJ, Yewdell JW.

PLoS Pathog. 2019 Feb 21;15(2):e1007567. doi: 10.1371/journal.ppat.1007567. eCollection 2019 Feb. Review.

3.

The Pathophysiological Relevance of the iNKT Cell/Mononuclear Phagocyte Crosstalk in Tissues.

Cortesi F, Delfanti G, Casorati G, Dellabona P.

Front Immunol. 2018 Oct 12;9:2375. doi: 10.3389/fimmu.2018.02375. eCollection 2018. Review.

4.

Potential advantages of CD1-restricted T cell immunotherapy in cancer.

Consonni M, Dellabona P, Casorati G.

Mol Immunol. 2018 Nov;103:200-208. doi: 10.1016/j.molimm.2018.09.025. Epub 2018 Oct 8. Review.

PMID:
30308433
5.

Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression.

Cortesi F, Delfanti G, Grilli A, Calcinotto A, Gorini F, Pucci F, Lucianò R, Grioni M, Recchia A, Benigni F, Briganti A, Salonia A, De Palma M, Bicciato S, Doglioni C, Bellone M, Casorati G, Dellabona P.

Cell Rep. 2018 Mar 13;22(11):3006-3020. doi: 10.1016/j.celrep.2018.02.058.

6.

Harnessing the CD1 restricted T cell response for leukemia adoptive immunotherapy.

Consonni M, de Lalla C, Bigi A, Dellabona P, Casorati G.

Cytokine Growth Factor Rev. 2017 Aug;36:117-123. doi: 10.1016/j.cytogfr.2017.06.007. Epub 2017 Jul 8. Review.

PMID:
28712863
7.

Of self-lipids, CD1-restricted T cells, and contact sensitization.

Casorati G, Dellabona P.

Eur J Immunol. 2017 Jul;47(7):1119-1122. doi: 10.1002/eji.201747112.

8.

Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.

Gorini F, Azzimonti L, Delfanti G, Scarfò L, Scielzo C, Bertilaccio MT, Ranghetti P, Gulino A, Doglioni C, Di Napoli A, Capri M, Franceschi C, Caligaris-Cappio F, Ghia P, Bellone M, Dellabona P, Casorati G, de Lalla C.

Blood. 2017 Jun 29;129(26):3440-3451. doi: 10.1182/blood-2016-11-751065. Epub 2017 May 2.

9.

miR-17∼92 family clusters control iNKT cell ontogenesis via modulation of TGF-β signaling.

Fedeli M, Riba M, Garcia Manteiga JM, Tian L, Viganò V, Rossetti G, Pagani M, Xiao C, Liston A, Stupka E, Cittaro D, Abrignani S, Provero P, Dellabona P, Casorati G.

Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):E8286-E8295. doi: 10.1073/pnas.1612024114. Epub 2016 Dec 5.

10.

T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes.

Mennonna D, Maccalli C, Romano MC, Garavaglia C, Capocefalo F, Bordoni R, Severgnini M, De Bellis G, Sidney J, Sette A, Gori A, Longhi R, Braga M, Ghirardelli L, Baldari L, Orsenigo E, Albarello L, Zino E, Fleischhauer K, Mazzola G, Ferrero N, Amoroso A, Casorati G, Parmiani G, Dellabona P.

Gut. 2017 Mar;66(3):454-463. doi: 10.1136/gutjnl-2015-309453. Epub 2015 Dec 17.

11.

The circulating microRNome demonstrates distinct lymphocyte subset-dependent signatures.

de Candia P, Torri A, Fedeli M, Viganò V, Carpi D, Gorletta T, Casorati G, Pagani M, Dellabona P, Abrignani S.

Eur J Immunol. 2016 Mar;46(3):725-31. doi: 10.1002/eji.201545787. Epub 2015 Dec 29.

12.

Group 1 CD1-restricted T cells and the pathophysiological implications of self-lipid antigen recognition.

Dellabona P, Consonni M, de Lalla C, Casorati G.

Tissue Antigens. 2015 Dec;86(6):393-405. doi: 10.1111/tan.12689. Epub 2015 Oct 30. Review.

PMID:
26514448
13.

A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse Model.

Wen X, Kim S, Xiong R, Li M, Lawrenczyk A, Huang X, Chen SY, Rao P, Besra GS, Dellabona P, Casorati G, Porcelli SA, Akbari O, Exley MA, Yuan W.

J Immunol. 2015 Aug 15;195(4):1459-69. doi: 10.4049/jimmunol.1500574. Epub 2015 Jul 8.

14.

Targeting leukemia by CD1c-restricted T cells specific for a novel lipid antigen.

Lepore M, de Lalla C, Mori L, Dellabona P, De Libero G, Casorati G.

Oncoimmunology. 2014 Dec 3;4(3):e970463. eCollection 2015 Mar.

15.

Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer.

Trajanoski Z, Maccalli C, Mennonna D, Casorati G, Parmiani G, Dellabona P.

Cancer Immunol Immunother. 2015 Jan;64(1):99-104. doi: 10.1007/s00262-014-1599-7. Epub 2014 Aug 28. Review.

PMID:
25164877
16.

A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.

Lepore M, de Lalla C, Gundimeda SR, Gsellinger H, Consonni M, Garavaglia C, Sansano S, Piccolo F, Scelfo A, Häussinger D, Montagna D, Locatelli F, Bonini C, Bondanza A, Forcina A, Li Z, Ni G, Ciceri F, Jenö P, Xia C, Mori L, Dellabona P, Casorati G, De Libero G.

J Exp Med. 2014 Jun 30;211(7):1363-77. doi: 10.1084/jem.20140410. Epub 2014 Jun 16.

17.

iNKT-cell help to B cells: a cooperative job between innate and adaptive immune responses.

Dellabona P, Abrignani S, Casorati G.

Eur J Immunol. 2014 Aug;44(8):2230-7. doi: 10.1002/eji.201344399. Epub 2014 May 30. Review.

18.

Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation.

de Candia P, Torri A, Gorletta T, Fedeli M, Bulgheroni E, Cheroni C, Marabita F, Crosti M, Moro M, Pariani E, Romanò L, Esposito S, Mosca F, Rossetti G, Rossi RL, Geginat J, Casorati G, Dellabona P, Pagani M, Abrignani S.

PLoS One. 2013 Sep 26;8(9):e75348. doi: 10.1371/journal.pone.0075348. eCollection 2013.

19.

Functional education of invariant NKT cells by dendritic cell tuning of SHP-1.

Napolitano A, Pittoni P, Beaudoin L, Lehuen A, Voehringer D, MacDonald HR, Dellabona P, Casorati G.

J Immunol. 2013 Apr 1;190(7):3299-308. doi: 10.4049/jimmunol.1203466. Epub 2013 Feb 20.

21.

Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.

Provasi E, Genovese P, Lombardo A, Magnani Z, Liu PQ, Reik A, Chu V, Paschon DE, Zhang L, Kuball J, Camisa B, Bondanza A, Casorati G, Ponzoni M, Ciceri F, Bordignon C, Greenberg PD, Holmes MC, Gregory PD, Naldini L, Bonini C.

Nat Med. 2012 May;18(5):807-815. doi: 10.1038/nm.2700.

22.

Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.

Tonti E, Fedeli M, Napolitano A, Iannacone M, von Andrian UH, Guidotti LG, Abrignani S, Casorati G, Dellabona P.

J Immunol. 2012 Apr 1;188(7):3217-22. doi: 10.4049/jimmunol.1103501. Epub 2012 Feb 29.

23.

Fine tuning by human CD1e of lipid-specific immune responses.

Facciotti F, Cavallari M, Angénieux C, Garcia-Alles LF, Signorino-Gelo F, Angman L, Gilleron M, Prandi J, Puzo G, Panza L, Xia C, Wang PG, Dellabona P, Casorati G, Porcelli SA, de la Salle H, Mori L, De Libero G.

Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14228-33. doi: 10.1073/pnas.1108809108. Epub 2011 Aug 15.

24.

An unexpected requirement for CD4+ T cells in anti-glycolipid antibody responses.

Dellabona P, Casorati G.

Immunol Cell Biol. 2011 May;89(4):499-501. doi: 10.1038/icb.2011.21. Epub 2011 Apr 12. No abstract available.

PMID:
21483447
25.

Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state.

de Lalla C, Rinaldi A, Montagna D, Azzimonti L, Bernardo ME, Sangalli LM, Paganoni AM, Maccario R, Di Cesare-Merlone A, Zecca M, Locatelli F, Dellabona P, Casorati G.

J Immunol. 2011 Apr 1;186(7):4490-9. doi: 10.4049/jimmunol.1003748. Epub 2011 Feb 25.

26.

High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells.

de Lalla C, Lepore M, Piccolo FM, Rinaldi A, Scelfo A, Garavaglia C, Mori L, De Libero G, Dellabona P, Casorati G.

Eur J Immunol. 2011 Mar;41(3):602-10. doi: 10.1002/eji.201041211. Epub 2011 Jan 18.

27.

On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies.

Dellabona P, Casorati G, de Lalla C, Montagna D, Locatelli F.

Clin Immunol. 2011 Aug;140(2):152-9. doi: 10.1016/j.clim.2010.11.015. Epub 2010 Dec 24. Review.

PMID:
21185785
28.

An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinoma.

Canderan G, Gruarin P, Montagna D, Fontana R, Campi G, Melloni G, Traversari C, Dellabona P, Casorati G.

PLoS One. 2010 Aug 9;5(8):e12014. doi: 10.1371/journal.pone.0012014. Erratum in: PLoS One. 2011;6(1).doi: 10.1371/annotation/df559170-4836-4bc7-a16d-44c7c6339cda. Campi, Gabriele [added].

29.

The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides.

Cecconi V, Moro M, Del Mare S, Sidney J, Bachi A, Longhi R, Sette A, Protti MP, Dellabona P, Casorati G.

Eur J Immunol. 2010 Jun;40(6):1603-16. doi: 10.1002/eji.200940123.

30.

iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.

Bellone M, Ceccon M, Grioni M, Jachetti E, Calcinotto A, Napolitano A, Freschi M, Casorati G, Dellabona P.

PLoS One. 2010 Jan 13;5(1):e8646. doi: 10.1371/journal.pone.0008646.

31.

Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.

Li X, Shiratsuchi T, Chen G, Dellabona P, Casorati G, Franck RW, Tsuji M.

J Immunol. 2009 Oct 1;183(7):4415-21. doi: 10.4049/jimmunol.0901021. Epub 2009 Sep 4. Erratum in: J Immunol. 2010 Jan 15;184(2):1121.

32.

Dicer-dependent microRNA pathway controls invariant NKT cell development.

Fedeli M, Napolitano A, Wong MP, Marcais A, de Lalla C, Colucci F, Merkenschlager M, Dellabona P, Casorati G.

J Immunol. 2009 Aug 15;183(4):2506-12. doi: 10.4049/jimmunol.0901361. Epub 2009 Jul 22.

33.

The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function.

Locci M, Draghici E, Marangoni F, Bosticardo M, Catucci M, Aiuti A, Cancrini C, Marodi L, Espanol T, Bredius RG, Thrasher AJ, Schulz A, Litzman J, Roncarolo MG, Casorati G, Dellabona P, Villa A.

J Exp Med. 2009 Apr 13;206(4):735-42. doi: 10.1084/jem.20081773. Epub 2009 Mar 23.

34.

B cell helper assays.

Abrignani S, Tonti E, Casorati G, Dellabona P.

Methods Mol Biol. 2009;514:15-26. doi: 10.1007/978-1-60327-527-9_2.

PMID:
19048210
35.

NKT-cell help to B lymphocytes can occur independently of cognate interaction.

Tonti E, Galli G, Malzone C, Abrignani S, Casorati G, Dellabona P.

Blood. 2009 Jan 8;113(2):370-6. doi: 10.1182/blood-2008-06-166249. Epub 2008 Oct 2.

36.

Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.

Cecconi V, Moro M, Del Mare S, Dellabona P, Casorati G.

Cytometry A. 2008 Nov;73(11):1010-8. doi: 10.1002/cyto.a.20603.

37.

Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.

Exley MA, Hou R, Shaulov A, Tonti E, Dellabona P, Casorati G, Akbari O, Akman HO, Greenfield EA, Gumperz JE, Boyson JE, Balk SP, Wilson SB.

Eur J Immunol. 2008 Jun;38(6):1756-66. doi: 10.1002/eji.200737389.

38.

Innate-like effector differentiation of human invariant NKT cells driven by IL-7.

de Lalla C, Festuccia N, Albrecht I, Chang HD, Andolfi G, Benninghoff U, Bombelli F, Borsellino G, Aiuti A, Radbruch A, Dellabona P, Casorati G.

J Immunol. 2008 Apr 1;180(7):4415-24.

39.

Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development.

Panattoni M, Sanvito F, Basso V, Doglioni C, Casorati G, Montini E, Bender JR, Mondino A, Pardi R.

J Exp Med. 2008 Feb 18;205(2):465-77. doi: 10.1084/jem.20070725. Epub 2008 Feb 11.

40.

Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.

Denkberg G, Stronge VS, Zahavi E, Pittoni P, Oren R, Shepherd D, Salio M, McCarthy C, Illarionov PA, van der Merwe A, Besra GS, Dellabona P, Casorati G, Cerundolo V, Reiter Y.

Eur J Immunol. 2008 Mar;38(3):829-40. doi: 10.1002/eji.200737518.

41.

MAGE-A3(161-175) contains an HLA-DRbeta4 restricted natural epitope poorly formed through indirect presentation by dendritic cells.

Marturano J, Longhi R, Casorati G, Protti MP.

Cancer Immunol Immunother. 2008 Feb;57(2):207-15. Epub 2007 Jul 13.

PMID:
17628799
42.

CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.

Thedrez A, de Lalla C, Allain S, Zaccagnino L, Sidobre S, Garavaglia C, Borsellino G, Dellabona P, Bonneville M, Scotet E, Casorati G.

Blood. 2007 Jul 1;110(1):251-8. Epub 2007 Mar 15.

43.

Invariant NKT cells sustain specific B cell responses and memory.

Galli G, Pittoni P, Tonti E, Malzone C, Uematsu Y, Tortoli M, Maione D, Volpini G, Finco O, Nuti S, Tavarini S, Dellabona P, Rappuoli R, Casorati G, Abrignani S.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3984-9. Epub 2007 Feb 27.

44.

Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology.

Tassi E, Facchinetti V, Seresini S, Borri A, Dell'antonio G, Garavaglia C, Casorati G, Protti MP.

Clin Cancer Res. 2006 Aug 15;12(16):4949-57.

45.

Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia.

Montagna D, Maccario R, Locatelli F, Montini E, Pagani S, Bonetti F, Daudt L, Turin I, Lisini D, Garavaglia C, Dellabona P, Casorati G.

Blood. 2006 Dec 1;108(12):3843-50. Epub 2006 Jul 25.

46.

Cutting edge: influence of the TCR Vbeta domain on the selection of semi-invariant NKT cells by endogenous ligands.

Schümann J, Mycko MP, Dellabona P, Casorati G, MacDonald HR.

J Immunol. 2006 Feb 15;176(4):2064-8.

47.

Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.

Moro M, Cecconi V, Martinoli C, Dallegno E, Giabbai B, Degano M, Glaichenhaus N, Protti MP, Dellabona P, Casorati G.

BMC Immunol. 2005 Dec 5;6:24.

48.
49.

CD4+ T cell immunity against the human papillomavirus-18 E6 transforming protein in healthy donors: identification of promiscuous naturally processed epitopes.

Facchinetti V, Seresini S, Longhi R, Garavaglia C, Casorati G, Protti MP.

Eur J Immunol. 2005 Mar;35(3):806-15.

50.

Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.

Casorati G, Locatelli F, Pagani S, Garavaglia C, Montini E, Lisini D, Turin I, Rossi F, Dellabona P, Maccario R, Montagna D.

Exp Hematol. 2005 Feb;33(2):212-8.

PMID:
15676215

Supplemental Content

Loading ...
Support Center